Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-08

FDA Approved: ALLERGY RELIEF — Supplemental Application (Publix Super Markets Inc)

View source ↗

Summary

FDA approved a supplemental application for Allergy Relief containing fexofenadine hydrochloride, submitted by Publix Super Markets Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLERGY RELIEF (cetirizine hydrochloride)

Snippet

SUPPL AP for ALLERGY RELIEF (FEXOFENADINE HYDROCHLORIDE)